Benton Susan 4

What Happened

• Susan Benton, a director of Opus Genetics, was granted 24,367 restricted stock units (RSUs) on April 20, 2026. The grant was recorded at a $0 acquisition price (code A — award/grant/acquisition). Because these are RSUs, there was no cash purchase or sale in this transaction.

Key Details

• Transaction date: 2026-04-20; Form 4 filed 2026-04-22 (timely filing).
• Security: 24,367 restricted stock units; acquisition price reported as $0.00.
• Shares owned after transaction: Not specified in the filing.
• Footnote: The RSUs vest on the earlier of (1) one year after the grant date or (2) the day before the issuer’s next annual stockholder meeting after the grant date, subject to Benton's continued service through the vesting date.
• Transaction code: A (award/grant/acquisition).

Context

• RSU grants are a form of compensation, not an open-market purchase or sale. They do not require immediate cash and only convert to shares if vesting conditions are met. Such awards are common for directors and don’t necessarily indicate a buying or selling signal by the insider.